Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    VolitionRx

    MCap

    USD76m

    Last close

    USD0.81

    ▲ 0.14 (20.90%)

    Canyon Resources

    MCap

    AUD262m

    Last close

    AUD0.19

    ▲ 0.02 (12.12%)

    Immix Biopharma

    MCap

    USD51m

    Last close

    USD1.82

    ▲ 0.12 (7.06%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

EMIS Group (AIM: EMIS)

Last close As at 21/11/2024

GBP19.20

— 0.00 (0.00%)

Market capitalisation

GBP1,232m

EMIS is a clinical software supplier to the primary, community and acute care markets in the UK and provides software to the community pharmacy market. Its Patient business provides medical and wellbeing information as well as transactional services to patients.

Latest Insights

View More

TMT | Flash note

EMIS Group — Final regulatory approval received for takeover

TMT | Flash note

EMIS Group — H123 on track; 21.3p interim dividend declared

TMT | Flash note

EMIS Group — CMA provisionally clears takeover of EMIS

TMT | Update

EMIS Group — FY22 results in line
Visit Website

Sector

TMT

Balance Sheet

Forecast net debt (£m)

N/A

Forecast gearing ratio (%)

N/A

Share Price Performance

Price Performance
% 1M 3M 12M
Actual (0.6) 32.2 3.3
Relative 3.7 40.4 1.3
52 week high/low 1934.0p/1310.0p

Financials

Edison Investment Research is terminating coverage on Kinarus Therapeutics (KNRS), Numis Corporation (NUM), EMIS Group (EMIS), Pixium Vision (PIX) and Treatt (TET). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.
Previously published reports can still be accessed via website

Y/E Dec Revenue (£m) EBITDA (£m) PBT (£m) EPS (fd) (p) P/E (x) P/CF (x)
2021A 168.2 54.7 43.5 55.0 34.9 24.2
2022A 175.4 59.4 48.1 60.9 31.5 24.8
2023E N/A N/A N/A N/A N/A N/A
2024E N/A N/A N/A N/A N/A N/A

Research

Flash note

TMT

EMIS Group — H123 on track; 21.3p interim dividend declared

Flash note

TMT

EMIS Group — CMA provisionally clears takeover of EMIS

TMT

Flash note

EMIS Group — Final regulatory approval received for takeover

Update

TMT

EMIS Group — FY22 results in line

Flash note

TMT

EMIS Group — Deal to proceed, pending Phase 2 investigation

Flash note

TMT

EMIS Group — More work to do to finalise takeover

Flash note

TMT

EMIS Group — Update on takeover process

Update

TMT

EMIS Group — On track

Update

TMT

EMIS Group — Supporting a more proactive health service

edison tv

TMT

EMIS Group FY21 results – executive interview

Update

TMT

EMIS Group — Strong FY21 drives upgrades
View All

Thematics

thematic

TMT

MediaWatch – One step forward, two steps back

thematic

TMT

MediaWatch – Encouragements and frustrations

thematic

TMT

MediaWatch – Glimpses of positivity

thematic

TMT

MediaWatch – Rinse and repeat
View All

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free